Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Sales (2023 - 2025)

Mangoceuticals' Return on Sales history spans 3 years, with the latest figure at 0.29% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 11.0% to 0.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.45%, a 31.0% decrease, with the full-year FY2025 number at 0.45%, down 31.0% from a year prior.
  • Return on Sales hit 0.29% in Q4 2025 for Mangoceuticals, up from 0.9% in the prior quarter.
  • Over the last five years, Return on Sales for MGRX hit a ceiling of 0.07% in Q3 2023 and a floor of 0.9% in Q3 2025.
  • Historically, Return on Sales has averaged 0.26% across 3 years, with a median of 0.17% in 2023.
  • Biggest five-year swings in Return on Sales: increased 14bps in 2024 and later crashed -75bps in 2025.
  • Tracing MGRX's Return on Sales over 3 years: stood at 0.11% in 2023, then crashed by -76bps to 0.19% in 2024, then tumbled by -59bps to 0.29% in 2025.
  • Business Quant data shows Return on Sales for MGRX at 0.29% in Q4 2025, 0.9% in Q3 2025, and 0.32% in Q2 2025.